KEVIN F MCLAUGHLIN Insider Trading $XLRN ACCELERON PHARMA INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for KEVIN F MCLAUGHLIN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of KEVIN F MCLAUGHLIN. KEVIN F MCLAUGHLIN is in Vericel Corp ($ASTM) and Director in Vericel Corp ($ASTM) and Executive V.P. and C.F.O. in PRAECIS PHARMACEUTICALS INC ($PRCS) and President & COO in PRAECIS PHARMACEUTICALS INC ($PRCS) and President and CEO in PRAECIS PHARMACEUTICALS INC ($PRCS) and President, COO & Secretary in PRAECIS PHARMACEUTICALS INC ($PRCS) and Senior V.P. and C.F.O. in PRAECIS PHARMACEUTICALS INC ($PRCS) and Senior Vice President & CFO in PRAECIS PHARMACEUTICALS INC ($PRCS) and Senior VP and CFO in PRAECIS PHARMACEUTICALS INC ($PRCS) and SVP, CFO and Treasurer in ACCELERON PHARMA INC ($XLRN).
KEVIN F MCLAUGHLIN in ACCELERON PHARMA INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of KEVIN F MCLAUGHLIN: SVP, CFO and Treasurer
Holdings: 10,681 shares
Current Value: $253,567
Latest Transaction: Feb 02 2021
$XLRN Market Capitalization: $879.48M
$XLRN Previous Close: $23.74
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of KEVIN F MCLAUGHLIN in ACCELERON PHARMA INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, XLRN, PRCS, ASTM
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 02 2021 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Option Exercise | A | 115.53 | 18,806 | 2,172,657 | 18,806 | |
| Feb 02 2021 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Grant | A | 0.00 | 4,868 | 0 | 10,681 | 5.8 K to 10.7 K (+83.74 %) |
| Jan 06 2021 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 123.50 | 4 | 494 | 5,813 | 5.8 K to 5.8 K (-0.07 %) |
| Jan 06 2021 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 122.85 | 296 | 36,364 | 5,817 | 6.1 K to 5.8 K (-4.84 %) |
| Jan 06 2021 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 121.89 | 499 | 60,823 | 6,113 | 6.6 K to 6.1 K (-7.55 %) |
| Jan 06 2021 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 120.43 | 700 | 84,301 | 6,612 | 7.3 K to 6.6 K (-9.57 %) |
| Jan 06 2021 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 124.45 | 300 | 37,335 | 7,312 | 7.6 K to 7.3 K (-3.94 %) |
| Jan 06 2021 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 124.47 | 667 | 83,021 | 7,612 | 8.3 K to 7.6 K (-8.06 %) |
| Jan 06 2021 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 123.49 | 600 | 74,094 | 8,279 | 8.9 K to 8.3 K (-6.76 %) |
| Jan 06 2021 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 125.49 | 200 | 25,098 | 8,879 | 9.1 K to 8.9 K (-2.20 %) |
| Jan 06 2021 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 124.28 | 713 | 88,612 | 9,079 | 9.8 K to 9.1 K (-7.28 %) |
| Jan 06 2021 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 123.54 | 800 | 98,832 | 9,792 | 10.6 K to 9.8 K (-7.55 %) |
| Jan 06 2021 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Payment of Exercise | F | 124.31 | 624 | 77,569 | 10,592 | 11.2 K to 10.6 K (-5.56 %) |
| Dec 15 2020 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Option Exercise | M | 40.61 | 2,590 | 105,180 | 26,262 | |
| Dec 15 2020 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Option Exercise | M | 30.17 | 24,986 | 753,828 | 5,163 | |
| Dec 15 2020 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Option Exercise | M | 27.97 | 7,700 | 215,369 | 0 | |
| Dec 15 2020 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Option Exercise | M | 41.20 | 7,252 | 298,782 | 0 | |
| Dec 15 2020 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 130.14 | 42,528 | 5,534,594 | 11,216 | 53.7 K to 11.2 K (-79.13 %) |
| Dec 15 2020 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Buy | M | 40.61 | 2,590 | 105,180 | 53,744 | 51.2 K to 53.7 K (+5.06 %) |
| Dec 15 2020 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Buy | M | 30.17 | 24,986 | 753,828 | 51,154 | 26.2 K to 51.2 K (+95.48 %) |
| Dec 15 2020 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Buy | M | 27.97 | 7,700 | 215,369 | 26,168 | 18.5 K to 26.2 K (+41.69 %) |
| Dec 15 2020 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Buy | M | 41.20 | 7,252 | 298,782 | 18,468 | 11.2 K to 18.5 K (+64.66 %) |
| Dec 11 2020 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Option Exercise | M | 41.20 | 3,100 | 127,720 | 7,252 | |
| Dec 11 2020 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Option Exercise | M | 40.61 | 100 | 4,061 | 28,852 | |
| Dec 11 2020 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Option Exercise | M | 30.17 | 100 | 3,017 | 30,149 | |
| Dec 11 2020 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Option Exercise | M | 27.97 | 200 | 5,594 | 7,700 | |
| Dec 11 2020 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Option Exercise | M | 41.20 | 100 | 4,120 | 10,352 | |
| Dec 11 2020 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Option Exercise | M | 40.61 | 1,873 | 76,063 | 28,952 | |
| Dec 11 2020 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Option Exercise | M | 30.17 | 1,051 | 31,709 | 30,249 | |
| Dec 11 2020 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Option Exercise | M | 27.97 | 400 | 11,188 | 7,900 | |
| Dec 11 2020 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Option Exercise | M | 41.20 | 548 | 22,578 | 10,452 | |
| Dec 11 2020 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 125.00 | 3,100 | 387,500 | 11,216 | 14.3 K to 11.2 K (-21.65 %) |
| Dec 11 2020 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Buy | M | 41.20 | 3,100 | 127,720 | 14,316 | 11.2 K to 14.3 K (+27.64 %) |
| Dec 11 2020 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 125.12 | 500 | 62,560 | 11,216 | 11.7 K to 11.2 K (-4.27 %) |
| Dec 11 2020 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Buy | M | 40.61 | 100 | 4,061 | 11,716 | 11.6 K to 11.7 K (+0.86 %) |
| Dec 11 2020 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Buy | M | 30.17 | 100 | 3,017 | 11,616 | 11.5 K to 11.6 K (+0.87 %) |
| Dec 11 2020 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Buy | M | 27.97 | 200 | 5,594 | 11,516 | 11.3 K to 11.5 K (+1.77 %) |
| Dec 11 2020 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Buy | M | 41.20 | 100 | 4,120 | 11,316 | 11.2 K to 11.3 K (+0.89 %) |
| Dec 11 2020 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 125.03 | 3,872 | 484,116 | 11,216 | 15.1 K to 11.2 K (-25.66 %) |
| Dec 11 2020 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Buy | M | 40.61 | 1,873 | 76,063 | 15,088 | 13.2 K to 15.1 K (+14.17 %) |
| Dec 11 2020 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Buy | M | 30.17 | 1,051 | 31,709 | 13,215 | 12.2 K to 13.2 K (+8.64 %) |
| Dec 11 2020 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Buy | M | 27.97 | 400 | 11,188 | 12,164 | 11.8 K to 12.2 K (+3.40 %) |
| Dec 11 2020 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Buy | M | 41.20 | 548 | 22,578 | 11,764 | 11.2 K to 11.8 K (+4.89 %) |
| Apr 10 2020 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Option Exercise | M | 41.20 | 17,226 | 709,711 | 11,000 | |
| Apr 10 2020 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Option Exercise | M | 30.17 | 10,000 | 301,700 | 31,300 | |
| Apr 10 2020 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Option Exercise | M | 27.97 | 10,000 | 279,700 | 8,300 | |
| Apr 10 2020 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Option Exercise | M | 41.20 | 12,774 | 526,289 | 28,226 | |
| Apr 10 2020 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Option Exercise | M | 24.11 | 4,000 | 96,440 | 0 | |
| Apr 10 2020 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 88.19 | 17,226 | 1,519,161 | 11,216 | 28.4 K to 11.2 K (-60.57 %) |
| Apr 10 2020 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Buy | M | 41.20 | 17,226 | 709,711 | 28,442 | 11.2 K to 28.4 K (+153.58 %) |
| Apr 10 2020 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 87.50 | 3,703 | 324,013 | 11,216 | 14.9 K to 11.2 K (-24.82 %) |
| Apr 10 2020 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 86.79 | 5,921 | 513,884 | 14,919 | 20.8 K to 14.9 K (-28.41 %) |
| Apr 10 2020 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 85.80 | 15,410 | 1,322,178 | 20,840 | 36.3 K to 20.8 K (-42.51 %) |
| Apr 10 2020 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 84.89 | 3,803 | 322,837 | 36,250 | 40.1 K to 36.3 K (-9.49 %) |
| Apr 10 2020 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 83.68 | 5,037 | 421,496 | 40,053 | 45.1 K to 40.1 K (-11.17 %) |
| Apr 10 2020 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 82.83 | 2,900 | 240,207 | 45,090 | 48 K to 45.1 K (-6.04 %) |
| Apr 10 2020 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Buy | M | 30.17 | 10,000 | 301,700 | 47,990 | 38 K to 48 K (+26.32 %) |
| Apr 10 2020 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Buy | M | 27.97 | 10,000 | 279,700 | 37,990 | 28 K to 38 K (+35.73 %) |
| Apr 10 2020 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Buy | M | 41.20 | 12,774 | 526,289 | 27,990 | 15.2 K to 28 K (+83.95 %) |
| Apr 10 2020 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Buy | M | 24.11 | 4,000 | 96,440 | 15,216 | 11.2 K to 15.2 K (+35.66 %) |
| Jan 24 2020 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Option Exercise | A | 52.99 | 24,334 | 1,289,459 | 24,334 | |
| Jan 24 2020 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Grant | A | 0.00 | 6,369 | 0 | 11,216 | 4.8 K to 11.2 K (+131.40 %) |
| Jan 03 2020 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 52.52 | 1,566 | 82,246 | 4,847 | 6.4 K to 4.8 K (-24.42 %) |
| Jan 03 2020 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 52.49 | 2,300 | 120,727 | 6,413 | 8.7 K to 6.4 K (-26.40 %) |
| Jan 03 2020 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 52.51 | 1,713 | 89,950 | 8,713 | 10.4 K to 8.7 K (-16.43 %) |
| Jan 03 2020 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 52.52 | 1,566 | 82,246 | 4,847 | 6.4 K to 4.8 K (-24.42 %) |
| Jan 03 2020 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 52.49 | 2,300 | 120,727 | 6,413 | 8.7 K to 6.4 K (-26.40 %) |
| Jan 03 2020 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 52.51 | 1,713 | 89,950 | 8,713 | 10.4 K to 8.7 K (-16.43 %) |
| Dec 17 2019 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 50.28 | 11,853 | 595,969 | 10,426 | 22.3 K to 10.4 K (-53.20 %) |
| Sep 10 2019 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 45.75 | 173 | 7,915 | 22,279 | 22.5 K to 22.3 K (-0.77 %) |
| Sep 10 2019 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 45.29 | 7,827 | 354,485 | 22,452 | 30.3 K to 22.5 K (-25.85 %) |
| Sep 10 2019 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 45.75 | 173 | 7,915 | 22,279 | 22.5 K to 22.3 K (-0.77 %) |
| Sep 10 2019 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 45.29 | 7,827 | 354,485 | 22,452 | 30.3 K to 22.5 K (-25.85 %) |
| Apr 11 2019 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 45.46 | 100 | 4,546 | 30,279 | 30.4 K to 30.3 K (-0.33 %) |
| Apr 11 2019 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 44.61 | 11,900 | 530,859 | 30,379 | 42.3 K to 30.4 K (-28.15 %) |
| Apr 04 2019 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 48.02 | 648 | 31,117 | 42,279 | 42.9 K to 42.3 K (-1.51 %) |
| Jan 29 2019 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Option Exercise | A | 41.64 | 28,000 | 1,165,920 | 28,000 | |
| Jan 29 2019 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Grant | A | 0.00 | 4,700 | 0 | 42,927 | 38.2 K to 42.9 K (+12.29 %) |
| Jan 04 2019 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 44.06 | 97 | 4,274 | 38,227 | 38.3 K to 38.2 K (-0.25 %) |
| Jan 04 2019 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 43.33 | 1,717 | 74,398 | 38,324 | 40 K to 38.3 K (-4.29 %) |
| Jan 04 2019 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 42.56 | 2,186 | 93,036 | 40,041 | 42.2 K to 40 K (-5.18 %) |
| Jan 04 2019 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 43.20 | 300 | 12,960 | 42,227 | 42.5 K to 42.2 K (-0.71 %) |
| Jan 04 2019 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 42.37 | 1,412 | 59,826 | 42,527 | 43.9 K to 42.5 K (-3.21 %) |
| Aug 31 2018 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Option Exercise | M | 27.97 | 12,500 | 349,625 | 18,300 | |
| Aug 31 2018 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 54.00 | 12,500 | 675,000 | 43,939 | 56.4 K to 43.9 K (-22.15 %) |
| Aug 31 2018 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Buy | M | 27.97 | 12,500 | 349,625 | 56,439 | 43.9 K to 56.4 K (+28.45 %) |
| Jul 03 2018 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Option Exercise | M | 24.11 | 25,000 | 602,750 | 4,000 | |
| Jul 03 2018 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 49.00 | 12,500 | 612,500 | 43,939 | 56.4 K to 43.9 K (-22.15 %) |
| Jul 03 2018 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 47.00 | 12,500 | 587,500 | 56,439 | 68.9 K to 56.4 K (-18.13 %) |
| Jul 03 2018 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Buy | M | 24.11 | 25,000 | 602,750 | 68,939 | 43.9 K to 68.9 K (+56.90 %) |
| Apr 04 2018 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 39.00 | 800 | 31,200 | 43,939 | 44.7 K to 43.9 K (-1.79 %) |
| Apr 04 2018 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 38.31 | 3,200 | 122,592 | 44,739 | 47.9 K to 44.7 K (-6.68 %) |
| Mar 05 2018 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Option Exercise | A | 40.61 | 30,825 | 1,251,803 | 30,825 | |
| Mar 05 2018 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Grant | A | 0.00 | 5,138 | 0 | 47,939 | 42.8 K to 47.9 K (+12.00 %) |
| Jan 04 2018 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Option Exercise | M | 5.28 | 6,250 | 33,000 | 0 | |
| Jan 04 2018 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Option Exercise | M | 3.88 | 6,251 | 24,254 | 0 | |
| Jan 04 2018 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 43.84 | 200 | 8,768 | 42,801 | 43 K to 42.8 K (-0.47 %) |
| Jan 04 2018 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 43.00 | 14,800 | 636,400 | 43,001 | 57.8 K to 43 K (-25.61 %) |
| Jan 04 2018 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Buy | M | 5.28 | 6,250 | 33,000 | 57,801 | 51.6 K to 57.8 K (+12.12 %) |
| Jan 04 2018 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Buy | M | 3.88 | 6,251 | 24,254 | 51,551 | 45.3 K to 51.6 K (+13.80 %) |
| Jan 04 2018 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 42.42 | 4,000 | 169,680 | 45,300 | 49.3 K to 45.3 K (-8.11 %) |
| Sep 14 2017 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 39.85 | 210 | 8,369 | 49,300 | 49.5 K to 49.3 K (-0.42 %) |
| Sep 14 2017 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 39.17 | 1,300 | 50,921 | 49,510 | 50.8 K to 49.5 K (-2.56 %) |
| Sep 14 2017 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 38.32 | 14,490 | 555,257 | 50,810 | 65.3 K to 50.8 K (-22.19 %) |
| Jul 07 2017 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Option Exercise | M | 7.12 | 18,750 | 133,500 | 0 | |
| Jul 07 2017 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Option Exercise | M | 5.28 | 3,150 | 16,632 | 6,250 | |
| Jul 07 2017 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 32.00 | 34,400 | 1,100,800 | 65,300 | 99.7 K to 65.3 K (-34.50 %) |
| Jul 07 2017 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Buy | M | 7.12 | 18,750 | 133,500 | 99,700 | 81 K to 99.7 K (+23.16 %) |
| Jul 07 2017 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Buy | M | 5.28 | 3,150 | 16,632 | 80,950 | 77.8 K to 81 K (+4.05 %) |
| Mar 14 2017 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Option Exercise | A | 30.17 | 41,300 | 1,246,021 | 41,300 | |
| Mar 14 2017 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Grant | A | 0.00 | 6,900 | 0 | 77,800 | 70.9 K to 77.8 K (+9.73 %) |
| Jan 06 2017 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 27.63 | 1,300 | 35,919 | 70,900 | 72.2 K to 70.9 K (-1.80 %) |
| Jan 06 2017 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 26.87 | 400 | 10,748 | 72,200 | 72.6 K to 72.2 K (-0.55 %) |
| Jan 04 2017 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Option Exercise | M | 3.88 | 10,000 | 38,800 | 6,251 | |
| Jan 04 2017 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Buy | M | 3.88 | 10,000 | 38,800 | 72,600 | 62.6 K to 72.6 K (+15.97 %) |
| Jul 07 2016 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Option Exercise | M | 3.88 | 5,000 | 19,400 | 16,251 | |
| Jul 07 2016 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Buy | M | 3.88 | 5,000 | 19,400 | 62,600 | 57.6 K to 62.6 K (+8.68 %) |
| Jul 06 2016 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Option Exercise | M | 5.28 | 15,300 | 80,784 | 9,400 | |
| Jul 06 2016 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 34.66 | 25,300 | 876,898 | 57,600 | 82.9 K to 57.6 K (-30.52 %) |
| Jul 06 2016 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Buy | M | 5.28 | 15,300 | 80,784 | 82,900 | 67.6 K to 82.9 K (+22.63 %) |
| May 25 2016 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Option Exercise | M | 5.28 | 300 | 1,584 | 24,700 | |
| May 25 2016 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 34.00 | 25,300 | 860,200 | 67,600 | 92.9 K to 67.6 K (-27.23 %) |
| May 25 2016 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Buy | M | 5.28 | 300 | 1,584 | 92,900 | 92.6 K to 92.9 K (+0.32 %) |
| Mar 07 2016 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Option Exercise | A | 27.97 | 30,800 | 861,476 | 30,800 | |
| Mar 07 2016 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Grant | A | 0.00 | 5,100 | 0 | 92,600 | 87.5 K to 92.6 K (+5.83 %) |
| Dec 23 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Option Exercise | M | 3.88 | 7,500 | 29,100 | 21,251 | |
| Dec 23 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Buy | M | 3.88 | 7,500 | 29,100 | 87,500 | 80 K to 87.5 K (+9.38 %) |
| Oct 09 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Option Exercise | M | 3.88 | 7,000 | 27,160 | 28,751 | |
| Oct 09 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 24.64 | 3,460 | 85,254 | 80,000 | 83.5 K to 80 K (-4.15 %) |
| Oct 09 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 24.12 | 3,540 | 85,385 | 83,460 | 87 K to 83.5 K (-4.07 %) |
| Oct 09 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Buy | M | 3.88 | 7,000 | 27,160 | 87,000 | 80 K to 87 K (+8.75 %) |
| Sep 11 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Grant | A | 0.00 | 40,000 | 0 | 80,000 | 40 K to 80 K (+100.00 %) |
| Sep 10 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Option Exercise | M | 3.88 | 1,500 | 5,820 | 35,751 | |
| Sep 10 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Option Exercise | M | 3.88 | 5,000 | 19,400 | 37,251 | |
| Sep 10 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 31.16 | 176 | 5,484 | 40,000 | 40.2 K to 40 K (-0.44 %) |
| Sep 10 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 30.45 | 724 | 22,046 | 40,176 | 40.9 K to 40.2 K (-1.77 %) |
| Sep 10 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 29.39 | 600 | 17,634 | 40,900 | 41.5 K to 40.9 K (-1.45 %) |
| Sep 10 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Buy | M | 3.88 | 1,500 | 5,820 | 41,500 | 40 K to 41.5 K (+3.75 %) |
| Sep 10 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 31.07 | 1,293 | 40,174 | 40,000 | 41.3 K to 40 K (-3.13 %) |
| Sep 10 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 30.22 | 2,500 | 75,550 | 41,293 | 43.8 K to 41.3 K (-5.71 %) |
| Sep 10 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 29.11 | 1,207 | 35,136 | 43,793 | 45 K to 43.8 K (-2.68 %) |
| Sep 10 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Buy | M | 3.88 | 5,000 | 19,400 | 45,000 | 40 K to 45 K (+12.50 %) |
| Aug 12 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Option Exercise | M | 3.88 | 1,500 | 5,820 | 42,251 | |
| Aug 12 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Option Exercise | M | 3.88 | 5,000 | 19,400 | 43,751 | |
| Aug 12 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 28.54 | 1,500 | 42,810 | 40,000 | 41.5 K to 40 K (-3.61 %) |
| Aug 12 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Buy | M | 3.88 | 1,500 | 5,820 | 41,500 | 40 K to 41.5 K (+3.75 %) |
| Aug 12 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 29.23 | 100 | 2,923 | 40,000 | 40.1 K to 40 K (-0.25 %) |
| Aug 12 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 28.51 | 4,900 | 139,699 | 40,100 | 45 K to 40.1 K (-10.89 %) |
| Aug 12 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Buy | M | 3.88 | 5,000 | 19,400 | 45,000 | 40 K to 45 K (+12.50 %) |
| Jul 30 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Option Exercise | M | 3.88 | 5,000 | 19,400 | 48,751 |